← Back to companies
Enlaza Therapeutics
0 open
La Jolla, California, United StatesFounded 202061+ employeesSeries A raisedSeries APrivate
Last round: series unknown · $15M · Sep 2025(4 rounds total)
Founded by Sanford J. Madigan, Sergio Duron
Backed by(11 investors)
J.P. Morgan Asset ManagementAvalon VenturesAmgen VenturesPfizer Venture InvestmentsFrazier Life SciencesAlexandria Venture InvestmentsSamsara BioCapitalPappas CapitalRegeneronBreguaLightspeed Venture Partners
Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-Lock™ platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.
Open Positions at Enlaza Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Enlaza Therapeutics?
